"Point in Time" Regulation Content
Pharmacy Operations and Drug Scheduling Act
Drug Schedules Regulation
B.C. Reg. 9/98
3
Bisacodyl and its salts except when sold in
(a) concentrations of 5 mg or less per oral dosage unit or 10
mg or less per rectal dosage unit/suppository, and
(b) package sizes containing no more than 50 mg of bisacodyl
1
Diclofenac and its salts, including but not limited to
diclofenac diethylamine, diclofenac sodium and diclofenac
potassium, except when sold as a single medicinal ingredient
for topical use on the skin in a concentration equivalent to
2% or less of diclofenac for not more than 7 days
2
Diclofenac diethylamine when sold as a single medicinal
ingredient for topical use on the skin for not more than 7
days,
(a) in concentrations greater than 1.16% and less than or
equal to 2.32%, and
(b) in package sizes containing greater than 2.6 g of
diclofenac diethylamine
3
Diclofenac diethylamine when sold as a single medicinal
ingredient for topical use on the skin for not more than 7
days,
(a) in concentrations greater than 1.16% and less than or
equal to 2.32%, and
(b) in package sizes containing no more than 2.6 g of
diclofenac diethylamine
3
Dimeticone 100 cSt solution 50% w/w for topical use in the
treatment of head lice
1
Minoxidil except when sold in preparations for topical use in
concentrations of 5% or less
3
Minoxidil foam for topical use in concentrations of 5% or less
for androgenetic alopecia (male or female pattern baldness or
hair loss)
3
Minoxidil in solutions for topical use in concentrations of 2%
or less
1
Omeprazole or its salts except when sold for the 14-day
treatment for frequent heartburn at a daily dose of 20mg in
package sizes of no more than 280mg of omeprazole
2
Omeprazole or its salts when sold for the 14-day treatment for
frequent heartburn at a daily dose of 20 mg in package sizes
of no more than 280 mg of omeprazole
1
Pancreatic extracts when sold in a dosage form that provides
more than 20 000 USP units of lipase activity per dosage unit
or indicated for the treatment of pancreatic exocrine
insufficiency
1
Pancreatin when sold in a dosage form that provides more than
20 000 USP units of lipase activity per dosage unit or
indicated for the treatment of pancreatic exocrine
insufficiency
1
Pancrelipase when sold in a dosage form that provides more
than 20 000 USP units of lipase activity per dosage unit or
indicated for the treatment of pancreatic exocrine
insufficiency
